Hematopoietic stem cells differentiate into a broad range of specialized blood cells. This process is tightly regulated and depends on transcription factors, micro-RNAs, and long non-coding RNAs. Recently, also circular RNA (circRNA) were found to regulate cellular processes. Their expression pattern and their identity is however less well defined. Here, we provide the first comprehensive analysis of circRNA expression in human hematopoietic progenitors, and in differentiated lymphoid and myeloid cells. We here show that the expression of circRNA is cell-type specific, and increases upon maturation.
INTRODUCTION
Each day more than 10 12 cells are produced in the bone marrow from hematopoietic stem cells (HSCs). HSCs differentiate into various progenitor cells, which in turn generate many types of myeloid and lymphoid cells (1) . This process requires a tight regulation of gene expression. Transcription factors, long non-coding RNAs (lncRNAs), and microRNAs (miRNAs) contribute to differentiation (2) (3) (4) . In addition to miRNA and lncRNA, also other non-coding RNAs emerge as important regulatory factors. Recently, it was shown that an alternative splicing mechanism can give rise to stable circular RNA (circRNA) with distinct regulatory capacity (5) (6) (7) .
CircRNA derive from transcripts that are back-spliced and joined head-to-tail at the splice sites (6, 8) . This covalent circularization of single stranded RNA molecules results in a novel backward fusion of two gene segments that can be of intronic and/or exonic origin (8) . The formation of circRNA relies on complementary sequences in flanking introns that bring two splicing sites in close vicinity, and thus facilitate the back-splicing event (9) . This circularization renders circRNA much more stable than linear RNAs (10) . circRNA do not contain poly-A tails. As a consequence, they are not detected by the most widely used RNAseq methods that are based on poly-A selection. Our current knowledge of circRNA expression is therefore still at its infancy.
Several functions have been attributed to circRNA (11) . They can serve as miRNA sponges (12, 13) , or as transcriptional activators (14, 15) . Furthermore, circRNA have been shown to segregate RNA binding proteins (16, 17) , and can even become translated into proteins through cap-independent translation initiation (5, 18) . CircRNA may also regulate the differentiation of HSCs (19) . Indeed, circRNA expression has been described in several blood cells (7, (20) (21) (22) . Together with recent reports on circRNA in neuronal and myocyte differentiation cells and in extracellular vesicles (5, 23) , these findings prompted us to interrogate which circRNA are expressed in hematopoietic cells and whether the expression of circRNA alters during hematopoietic differentiation. circRNA can be identified by their unique back-spliced junction, which results in chimeric reads alignment in the RNA-seq data. This feature distinguishes them from linear RNA (6); Figure 1A ). Here, we used previously published transcriptome deep-sequencing data on primary human hematopoietic cells to define the expression pattern of circRNA during differentiation. This comprehensive analysis identified >59.000 circRNA in hematopoietic cells, including >14.000 newly annotated circRNA. We found that circRNA expression is cell-type specific and alters during differentiation. Furthermore, differentiated cells contain substantially higher levels of circRNA. We conclude that circRNA expression is widespread in hematopoietic cells, which warrants their further functional characterization.
MATERIAL AND METHODS

Data set selection
The SRA repository from NCBI was searched for datasets of human hematopoietic cells that contained paired-end data with long reads (>100nt), at least 20 million reads/sample, and that did not use Oligo-dT for cDNA preparation, or 5' or 3' capture methods for library preparation. The selected data set (accession GSE74246/SRP065216) from (24) used total RNA and the TruSeq/NEB Next Ultra library preparation kit. For granulocytes, RBC and platelets, we used datasets that used ribosomal RNA-depleted total RNA for sample preparation. Accession numbers for platelets: ERR335311, ERR335312 and ERR335313 (25) ; for RBCs: SRR2124299, SRR2124300, SRR2124301 and SRR2038798 (26, 27) , and for granulocytes: ERR789064, ERR789082, ERR789195 and ERR789201 (28) .
circRNA identification and analysis.
Data sets were aligned to the human genome (GRCh37 / hg19-release75) using STAR version 2.5.2b allowing for chimeric detection (see Supplementary Methods) . The output file of STAR was analysed with DCC 0.4.4 (29) and CircExplorer2 (CE) 2.01 (30) to detect, filter and annotate circRNA (see supplementary method). DCC was used for detection of linear reads at the circRNA coordinates (using the option -G). For both CE and DCC, we used GRCh37/hg19 genome annotations.
circRNA expression was considered low confidence detection when at least 2 junction reads were found in at least 1 sample by both DCC and CE, and high confidence detection when at least 2 junction reads were found in all replicates of one specific cell type.
Junction read counts were normalized to reads per million mapped reads (RPM). The maximal circRNA length was calculated with the exon length information provided by the CE annotations. These annotations were then used to calculate the first and last circularized exon.
For differential expression analysis of CircRNA in hematopoiesis cell, we calculated the log2 fold-change for each comparison of populations (see Supplemental method; (5, 23) Red blood cell fractionation was performed with a Percoll-Urografin gradient as previously described (33) .
Flow cytometry. Red blood cell fractions were washed in PBS+1% bovine serum albumin (BSA, Sigma-Aldrich), and incubated for 30min at 4°C with anti-CD71-APC (Miltenyi;
Clone AC102) and Thiazole orange (TO) (Sigma-Aldrich, 100 ng/mL). Cells were washed once with PBS+1% BSA and acquired on LSR Fortessa (BD). Data analysis was performed with FlowJo version X (Tree Star).
RNA extraction. RNA was extracted with Trizol (Life Technologies) according to the manufacturer's protocol. RNA was resuspended in RNAse-free water. Half of the isolated RNA was treated for 15 min at 37°C with 8 units/µg RNAseR (Epicentre) in water supplemented with the digestion buffer provided by the manufacturer. RNAseR-treated and untreated control samples were purified with mini Quick-spin columns (Roche). cDNA preparation was performed with random hexamers using Super Script III reverse transcription (Invitrogen) according to the manufacturer's protocol.
Primers and PCR. Primers were designed with CircInteractome (16) and with the NCBI primer blast tool (34) , and manufactured by Sigma. Alternatively, the first and last 100nt of the circRNA junction were joined and used to blast for primer pairs. Primer sequences used to detect linear and circular RNA are found in Supplementary Table 5 . PCRs were performed with ReddyMix PCR Master-Mix (Thermo-Fischer), and products were run on 2% agarose gels.
RESULTS
circRNAs are broadly expressed in hematopoietic cells
To determine which circRNA are expressed in hematopoietic cells, we used the RNA-seq data set of Corces et al. (24) that contained a broad range of hematopoietic progenitors and differentiated immune cells ( Figure 1B ). This data set was generated without selection for polyA+ mRNA, which allowed the identification and quantification of both circular and linear RNAs. Samples were included in the analysis when they reached a sequencing depth of at least 20M reads and when paired-end reads had a length of at least 100 bases.
This cut-off resulted in 2-3 replicates per cell type.
We used two different tools for circRNA detection, i.e. DCC (29) and CircExplorer2 (CE) (30) . Both tools allow for fast and accurate detection of circRNA by detecting back-splice junction reads of circRNA from RNA-seq data with a low false positive rate (reviewed in (35) ). We used a cut-off for circRNA detection when at least 2 junction reads were measured in at least 1 sample of one specific population (7) ( Figure 1C , Supplementary   Table S1 ). This analysis identified 13.898 different circRNA with DCC and 5072 circRNA with CE. 4103 circRNA were detected with both tools, of which 3100 and 3107 were annotated in circBase (36) and CircNet (37) respectively ( Figure 1D ). 428 circRNA (10.4%) were newly identified circRNA that were not annotated in either data base ( figure 1D ). Only 16 circRNA (0.4%) of the 4103 circRNA derived from intronic junctions (Supplementary Figure S1A ). The vast majority of the 4103 circRNA (4087 circRNA; 99.6%) contained exon-exon junctions.
We validated the expression of several highly expressed circRNA and the linear mRNA variants of the same gene by RT-PCR ( Figure 1E ) in human peripheral blood mononuclear cells (PBMC). Similar to the linear RNA products, all circRNA products identified with DCC or CE that we tested by RT-PCR were also detected in PBMCs ( Figure 1F ). The sensitivity of linear RNA, but not of circRNA, to the exonuclease ribonuclease R (RNAse R) confirmed the identity of the tested circRNA.
circRNA generation, size and distribution in hematopoietic cells
We next determined which genes and which exons were used for the generation of circRNA. The distribution of the identified circRNA per chromosome was similar to the distribution of all coding and non-coding genes (Figure 2A ). When analyzing the biological processes of circRNA-generating genes, they were enriched in housekeeping functions (Supplementary Figure S1B ). The predicted numbers of exons used by circRNA is on average 5.96 exons as determined by CE based on the known linear exon usage, with a minimum of 1 exon and a maximum of 56 exons ( Figure 2B ). The calculated length of the circRNA based was on average 1057 nucleotides ( Figure 2C ). We next interrogated how many circRNA variants are generated from a gene. To this end, we calculated all different back-splice junction reads found per gene in hematopoietic cells. This analysis revealed that 930 genes (53%) generated only one circRNA variant.
However, the overall expression of circRNA variants is between 1 and 26 variants per gene with a mean of 2.3 circRNA/gene ( Figure 2D ). If circRNA would be a random event, the maximum possible number of circRNA should increase near-exponentially as the number of exons per transcripts increases ( Figure 2E , blue line). There was, however, no overt correlation between the detected number of circRNA variants per gene and the number of exons per transcripts, suggesting that the generation of circRNA is not a random event ( Figure 2E ; compare the data points with blue line).
Finally, we questioned which exon of the linear transcript is used by circRNA as the starting exon for circularization. In line with the canonical splicing rules (38) , circRNA in hematopoietic cells barely use the first exon ( Figure 2F ). Rather, circRNA favor the second exon of a transcript as starting exon, which is found in 1197/4103 circRNA (29.2%) ( Figure   2F ). We also determined which exon is used for back-splicing, referred to as the end circularized exon. Again, the last exon of a linear transcript was not used ( Figure 2G ).
However, we could not detect a clear preference for a specific end exon ( Figure 2G ).
CircRNA expression in hematopoiesis alters upon differentiation
We next interrogated whether the expression of circRNA alters during hematopoietic differentiation. We focused on circRNA that were identified with high confidence by both DCC and CE with at least 2 junction reads ( Figure 1C ), and that were found in each biological replicate of one specific cell population. This analysis yielded 489 high confidence circRNA ( Figure 3A , Supplementary Table S1 ).
Principal component analysis (PCA) of the circRNA expression accurately recapitulated the previously described distribution of the linear mRNA in hematopoietic cell populations (24) . HSC and progenitor cells are located at the intersection of the differentiated myeloid and lymphoid cells ( Figure 3B ). Differentiated myeloid cells clustered with each other, away from the progenitors, and in opposite directions as the mature lymphoid cells ( Figure   3B ). Unsupervised clustering based on circRNA expression also showed a clear clustering of HSCs with progenitors in a heat map, away from differentiated cell populations ( Figure   3C ). We observed that lymphocytes had the highest levels of circRNA expressed, based on the sum of all circRNA RPM ( Figure 3D ). The number of distinct circRNA, however, was similar in various cell populations, indicating that the abundance of circRNA, but not the variety of circRNA, was increased in B cells, CD4 + and CD8 + T cells, and in NK cells
CircRNA expression during hematopoietic differentiation is cell-type specific
To determine the cell-type specific expression of circRNA, we looked in more detail at circRNA of the highly confident 489 circRNA detected in Figure 3 , which displayed a log2FoldChange ≥4 (≥16 times enriched) in any comparison between two populations.
This cut-off identified 187 circRNA ( Figure 4A , Supplementary Table S2 ). K-means clustering (k=15) showed cell-type specific circRNA expression pattern ( Figure 4A , B). Clusters 2, 3, 10, 11, and 15 include circRNA expressed by the progenitors ( Figure 4B ).
CircRNA in cluster 10 were mainly expressed in early progenitors, i.e. HSCs, MMPs, and LMPPs. Cluster 2 circRNA were more restricted to HSCs and MPPs, but also showed circRNA expression in lymphoid cells. Clusters 3 and 15 showed the signature of CLPs, concomitant with low expression in differentiated lymphoid cells. Cluster 11 circRNA were shared between HSC and MPPs, and with NK cells.
Lymphoid cells specific circRNA were represented by clusters 6-9 ( Figure 4B ). Cluster 4 was specific for B cells, cluster 13 for CD4 + T cells, and cluster 5 for NK cells. Cluster 9 and 12 showed a mixed lymphoid signature that was enriched for NK cells. Myeloid cell specific circRNA were present in cluster 1 and 14 ( Figure 4B ). Cluster 1 was erythroid specific and 14 mostly monocyte-specific with some background expression in CMP and CLP. We validated the distribution of several circRNA in blood cell subsets. Indeed, circ-FNDC3B (exon 5-6) was broadly expressed with the highest expression levels in NK cells.
Circ-ELK4 (exon 4-3) and circ-MYBL1 (exon 12-7), and the newly identified circ-SLFN12L Figure   S1C ).
(cluster 2-3) show the highest expression in T cells and NK cells (Supplementary
Interestingly, different circRNA variants generated from the same gene were detected in different clusters ( Figure 4B ). For example, circ-BACH1 (exon 3 to 4) was preferentially expressed in monocytes (cluster 14), whereas circ-BACH1 (exon 2 to 4) was increased in HSCs and MPPs (cluster 10). This finding was confirmed by RT-PCR (Supplementary Figure S1D ). Likewise, different variants of circ-AKT3 (clusters 7, 9, and 11) and circ-CCDC91 circRNA (clusters 5 and 6) were expressed across lymphoid cells. In conclusion, our analysis shows that the expression of circRNA is cell-type specific.
The ratio of circRNA over linear RNA alters with differentiation
We next investigated how the expression levels of circRNA compares with that of the corresponding linear RNA. Because circRNA detection is restricted to the junction reads, the levels of linear mRNA expression are also defined by comparing the number of reads at the start and at the end position of the circRNA ( Figure 5A We plotted the CLR against the circRNA expression for each hematopoietic population. 82 circRNA showed a CLR>0.5, indicating that these circRNA reached at least 50% of the levels of the linear RNA ( Figure 5B , gray dots). The 187 circRNA used to determine celltype specific circRNA expression in Figure 4 followed the same expression pattern ( Figure   5B , blue dots). The expression level for several circRNA reached even higher expression levels than the corresponding linear RNAs (CLR >1; Figure 5B , Supplementary Table S3 ).
The number of circRNA with a CLR>1 was highest in differentiated lymphoid cells, i.e. B
cells, T cells and NK cells.
We next determined if the ratio between circular and linear RNAs alters during hematopoietic differentiation. To this end, we plotted all circRNA with a CLR >0.5 (n=82) in a heat map ( Figure 5C ). Some circRNA like circ-NEIL3 (exon 8-9) or circ-ANKRD12 (exon 2-8) retained a high CLR in all cell populations. In contrast, the CLR of circ-SLC8A1 (exon 2) was only high in GMPs and in monocytes. The CLR of circ-AFF2 (exon 3) was high in MEPs and monocytes as well as in T cells ( Figure 5C ). Circ-RERE (exon 3) showed the highest CLR in NK cells, but was also found in B cells and T cells, albeit with lower CLRs ( Figure 5C ). Combined, these findings show that the use of circRNA and their correlation to the linear RNA is cell-type specific and changes during hematopoiesis.
Red blood cells and platelets have high expression levels of circRNA
Maturation of red blood cells is accompanied with an increase in heterochromatin and condensation of the nucleus, followed by extrusion of the nucleus. Platelets are shed from megakaryocytes. Both red blood cells and platelets undergo their final steps of maturation in absence of active gene transcription (39) . To investigate the expression levels of circRNA in RBC and platelets, we first used publicly available RNA expression data of platelets, red blood cells (RBC), and granulocytes isolated from peripheral blood (25) (26) (27) (28) .
By combining DCC and CE and using the low-confidence cut-off of 2 junction reads in at least 1 replicate of one specific cell population, we identified 59.011 circRNA, of which 28.841 and 42.082 were annotated in circBase and CircNet, respectively ( Figure 6A ). Over 14.100 circRNA (23.9%) were thus newly identified in this data set. Of the 59.011 identified circRNA, platelets express the highest numbers of circRNA (47.654), followed by RBCs (27.409 ) and granulocytes (8.925) ( Supplementary Table S4 ). With the high confidence cut-off of 2 junction reads in each biological replicate of one cell type, we detected 10.729 circRNA in platelets, 5.878 circRNA in RBCs, and 1.989 circRNA in granulocytes ( Figure   6B , Supplementary Table S4 ). Of these, both shared and cell-type specific circRNA were detected ( Figure 6B ). Platelets not only contained the highest numbers of different circRNA, but also clearly outnumbered RBCs and granulocytes with the overall RPM of circRNA RPM ( Figure 6C ).
We next determined the number of circRNA variants that are expressed per gene in the three different cell types ( Figure 6D ). Of note, none of the three cell types were included in the data set of Figure 1 The high prevalence of circRNA in platelets and RBCs is also reflected by the high CLR ( Figure 6E ). Concomitant with the loss of de novo transcription in enucleated cells, RBCs and platelets contain high levels of circRNA, and a significant number of circRNA have a high CLR. 7.8% of the circRNA expressed in platelets had a CLR > 1 (n=838). Similarly, RBCs had 9.87% circRNA with a CLR >1 (n=580), and 6.13% (n=122) in granulocytes ( Figure 6E ).
We then determined how the circRNA expression pattern of these three cell types corresponded to the circRNA usage in the respective progenitor. The hematopoiesis dataset (24) and the differentiated myeloid cells (25) (26) (27) (28) were two different data sets generated with different methods, i.e. total RNA and with ribosomal RNA depletion, respectively. We therefore used the CLR of each circRNA for comparison of progenitors and differentiated cells, i.e. MEP and platelets; erythroblasts and RBCs; and GMP and granulocytes. We included the circRNA and the corresponding linear mRNAs in this analysis that had at least 0.1 RPM each ( Figure 6F ; Supplementary Table S4 ). The circRNA that have a CLR>0.5 (gray) or of a CLR>1 (colored) are more prevalent in mature platelets, RBCs and granulocytes than in the precursor populations ( Figure 5F ). In addition, the circRNA with a CLR>0.5 in mature cells barely overlap with those of the precursor cells ( Figure 5F ). Combined, we conclude that circRNA are highly expressed in differentiated myeloid cells, and that the highest relative levels are detected in the enucleated RBCs and platelets.
CircRNA expression retains in aging RBCs
RBCs have a life span of 120 days, and during this period RBCs age (40) . We therefore analysed if and how the linear and circular RNA expression altered during RBC maturation and ageing. To separate reticulocytes and young erythrocytes from old erythrocytes we used a Percoll-Urografin gradient ((33), Figure 7A ). The maturation status of reticulocytes and the erythrocytes was confirmed with CD71 expression and the nucleic acid content with Thiazole Orange (TO) by flow cytometry ( Figure 7A ). Upon ageing, the expression of CD71 is lost ( Figure 7B ) and the TO staining ( Figure 7C ) is decreased.
We used these four fractions of red blood cells to detect RBC-specific circRNA with relatively high expression and CLR over 0.5 and their linear mRNAs by RT-PCR ( Figure   7D ). During ageing, only the highly stable β−ACTIN mRNA, and RGCC mRNA is detected in mature erythrocytes ( Figure 7D was specifically detected in mature reticulocytes ( Figure 7B ). Thus, circRNA expression is stably maintained during RBC ageing, suggesting that circRNA may be involved in RBC function.
In conclusion, we present here an analysis of circRNA in hematopoietic cells. We demonstrate, that circRNA expression is cell type specific, and that mature cells both of lymphoid and of myeloid origin contain more circRNA.
DISCUSSION
CircRNA can drive a subset of cellular functions (5, 12, 41 ), yet their role in gene regulation and expression in human hematopoietic cells is not well understood. To our knowledge, we here provide the first comprehensive analysis of circRNA expression during hematopoiesis. We identified over 14.000 novel circRNA, which significantly extends the list of currently annotated circRNA in the human transcriptome. How specific these newly identified circRNA are for hematopoietic cells is yet to be determined.
Because the identified circRNA are formed both from genes with general functions and from hematopoietic specific genes, and because the CLR indicates a cell-type specific enrichment of circRNA, we postulate that at least some of the identified circRNA should be cell-type specific.
Similar to differentiating neurons and myocytes (5, 23) the expression levels of circRNA increase during hematopoietic differentiation. This increase could be a mere result of accumulation of stable circRNA during differentiation. However, we show here that some circRNA are preferentially expressed in progenitors. For example, the expression levels of circ-FIRRE (exon 5-10) was high in all progenitors except from CLPs, and it was significantly reduced upon differentiation ( Figure 4B ). Another product of the FIRRE gene, the lncRNA FIRRE was shown to regulate part of the pluripotency of embryonic stem cells (ESC) via Repeat RNA Domains (RRD). Intriguingly, we observed that circ-FIRRE (5-10) also contains all RRDs described for the LncRNA FIRRE. It is therefore tempting to speculate that some of the effects that are attributed to the lncRNA FIRRE could also be exerted by the circular FIRRE RNA.
Interestingly, the exon usage for circRNA generation -as we describe for circ-BACH1can alter during differentiation. Several studies showed that alternative splicing during hematopoietic differentiation is primarily driven by exon skipping (2, 39) . The original hypothesis was that skipped exons were degraded via non-sense mediated decay.
However, these exons can also be used for the formation of circRNA (42) . As exon skipping is increased during late erythropoiesis (39) , and circRNA expression is then increased, it is tempting to speculate that exon skipping contributes to the production of circRNA in erythrocytes. However, exon skipping cannot be the sole and perhaps even not the major source of circRNA. Many circRNA contain several exons, and the generation thereof appears cell type specific and differentiation dependent. In addition, a subset of circRNA display an increased expression over the linear variant. Combined, these data suggest a highly orchestrated production of circRNA. Future investigations should reveal how the formation of circRNA relates to the exon skipping, or to other regulatory events.
Platelets and erythrocytes contain high levels of circRNA. This can at least in part be explained by the degradation of linear transcripts (26) . Interestingly, the circRNA expression of erythroblast and MEP does not fully overlap with the differentiated RBCs and platelets. This again suggests that in addition to accumulation of stable circRNA in enucleated cells also the generation of circRNA may alter during differentiation. Furthermore, platelets release specific circRNA in extracellular vesicles (43) , which may alter the composition of the remaining circRNA. This specific release also suggests that circRNA may be involved in platelet-associated cellular processes.
The function of circRNA is to date not well understood (44) . Whereas some circRNA can serve as a miRNA sponge (45) , this does not apply to most of the currently known circRNA (13, 46) . CircRNA may also serve as sponges for RNA-Binding Proteins (11, 17) , or crosstalk with the transcriptional machinery (14, 15) . Recent studies show that circRNA can be also translated into functional protein (5, 18, 47) . Thus, the function of circRNA is most probably diverse. Here we provide a comprehensive analysis of circRNA in hematopoietic cells. Future studies will reveal how circRNA can contribute to the regulatory processes in hematopoietic cells, and possibly in the make up of the proteome. Furthermore, circRNA may be a useful tool to distinguish diseased from healthy hematopoietic cells and be used as potential biomarkers, as previously suggested for several other types of cancers (48) . i.e. (2) (3) (4) and (3) (4) . Supplementary Table 3 : List of circRNA and their CLR ratio from Figure 5B , the populations are found in different tabs. Figure 5 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 10 -2 10 -1 10 0 10 1 10 2 circRNA with CLR<0.5 
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